170 evolution "https:" "https:" "https:" "https:" "https:" "https:" "ISCTE IUL" positions at King's College London in United Kingdom
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
Transition & Outcomes Department, contributing to the development and delivery of a portfolio of student leadership, partnership and student success initiatives aligned with institutional strategic priorities
-
) for professional development. This entitlement, from the Concordat to Support the Career Development of Researchers, applies to Postdocs, Research Assistants, Research and Teaching Technicians, Teaching Fellows and
-
. The post will contribute to the development and evaluation of trustworthy AI approaches that support high-quality clinical documentation and safer decision-making in dental care. You will help deliver co
-
research and administrative activities, within guidelines provided by the PI and in collaboration with senior colleagues, and contribute to wider project development. You will determine the most appropriate
-
(Projects) within the Early Career Researcher Institute, you will play a vital role in delivering high‑quality learning, development and support activities that empower Imperial’s early career researchers
-
: The Build Director will oversee the design, development and implementation of software applications within the university. This role is crucial in ensuring that the University's applications support Student
-
staff have developed a body of research evidence that has informed the development of new treatment services for alcohol, smoking and drug problems in the UK. This work ranges from trials of new therapies
-
this field. Over the last 30 years, our staff have developed a body of research evidence that has informed the development of new treatment services for alcohol, smoking and drug problems in the UK. This work
-
31st May 2027 with a possibility of an extension. Research staff at King’s are entitled to at least 10 days per year (pro-rata) for professional development. This entitlement, from the Concordat
-
for helping to continue the successful delivery and future development of ongoing epilepsy research projects funded by the UK Epilepsy Research Institute, Medical Research Council and Angelini Pharma